US’s “New” Proposed TPP Intellectual Property Chapter Still Requires Patents on Medicinal Forms With “Distinguishing Features”
The US has evergreened its patent proposal requiring patents on new forms of known/existing medicines by requiring patents on medicines with “distinguishing features.” This is the wine of old IP maximalism – an elixir for Big Pharma – in a…